BioCentury
ARTICLE | Company News

Biota, Daiichi Sankyo sales and marketing update

October 25, 2010 7:00 AM UTC

Daiichi Sankyo launched Inavir laninamivir dry powder inhaler in Japan to treat influenza. One 40 mg treatment costs ¥4,161 ($51.18). The second-generation long-acting neuraminidase inhibitor (LANI)...